The evolving role of biomarker patents in personalized medicine
- PMID: 24448456
- DOI: 10.1038/clpt.2013.185
The evolving role of biomarker patents in personalized medicine
Abstract
Patents are commonly granted for the use of biomarkers in making medical decisions. However, the US Supreme Court recently changed the landscape with a unanimous decision that patents cannot cover discoveries of basic correlations in nature, such as those relating biomarkers to particular clinical outcomes. Subsequent court decisions have overturned patents on genetic and other diagnostic methods involving purely mental processes, but processes integrating biomarkers in practical clinical steps can still earn intellectual property protections.
Similar articles
-
An overview of a recent court challenge to the protection of biomarkers as intellectual property.Clin Chim Acta. 2011 May 12;412(11-12):802-5. doi: 10.1016/j.cca.2011.01.024. Epub 2011 Feb 20. Clin Chim Acta. 2011. PMID: 21315704 Review.
-
Who owns federally funded research? The Supreme court and the Bayh-Dole act.N Engl J Med. 2011 Sep 29;365(13):1167-9. doi: 10.1056/NEJMp1109168. Epub 2011 Aug 31. N Engl J Med. 2011. PMID: 21879888 No abstract available.
-
Challenging gene patents. Myriad ruling will impact personalized medicine.Mod Healthc. 2013 Apr 15;43(15):8-9. Mod Healthc. 2013. PMID: 23738477 No abstract available.
-
Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.Am Univ Law Rev. 2013;63(1):173-217. Am Univ Law Rev. 2013. PMID: 25335200
-
Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.Regen Med. 2014 Mar;9(2):191-200. doi: 10.2217/rme.13.93. Regen Med. 2014. PMID: 24750060 Review.
Cited by
-
Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?Health Care Anal. 2019 Mar;27(1):45-59. doi: 10.1007/s10728-017-0347-5. Health Care Anal. 2019. PMID: 28936750
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
